Daytime agitation in dementia fluctuates day-to-day, and a 2026 explanatory study from Liu et al. used contactless under-mattress sensors in 55 long-term-care residents and an external 17-person home-monitoring cohort to show that lower nocturnal respiratory rate and higher activity instability robustly predict next-day agitation occurrence — but not severity.1 Research Highlights Lower breathing rate: adjusted …
The risperidone-stroke link in dementia is one of the longest-running safety signals in geriatric psychiatry, anchoring the FDA’s 2005 black-box warning on atypical antipsychotic mortality. Popular framing reduces it to “antipsychotics cause stroke in dementia” — a true sentence that flattens a multi-axis decision. Choma’s 2025 analysis of UK primary care records is the largest …
Phenibut (brand name “Noofen”) is a neuropsychiatric drug originally synthesized in St. Petersburg, Russia by a team of researchers at the Department of Organic Chemistry of the Herzen Pedagogic Institute. By the 1960s, phenibut was introduced as a pharmaceutical agent in Russia for the treatment of various medical conditions including: anxiety, insomnia, and PTSD. Since …
Rhodiola rosea has become a popular dietary supplement in recent years. Rhodiola rosea is a plant derived from the Crassulaceae family and is typically extracted from mountainous, cold climates where it can be found growing on cliffs; it is most commonly found in higher altitudes. For centuries, many people have used Rhodiola rosea as a …